ARTICLE | Company News
PharmaGenoma Inc. sales and marketing update
October 12, 2009 7:00 AM UTC
PharmaGenoma's HairDX LLC subsidiary launched its HairDX Genetic Test for Hair Loss in Europe to predict the risk of developing androgenetic alopecia. The test has CE Mark approval. The price is €198...